Augmedix Announces Inaugural AI Advisory Council Members
September 21, 2023
Healthcare
-
-
Nemaura Medical Provides Update on Nasdaq Compliance Status and Process
September 14, 2023
-
Biotricity Unveils a New Digital Presence, Highlighting its Expanding Technology Portfolio and Cutting-Edge Innovations
September 13, 2023
-
Nemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program
September 13, 2023
-
22nd Century Group (XXII) Adds 1,200 Drug Store Locations Selling VLN® in Five States
September 12, 2023
-
AXIM® Biotechnologies Develops First Non-Invasive, Rapid, Point-of-Care, Diagnostic Test for Parkinson’s Disease
September 12, 2023
-
Petros Pharmaceuticals Provides Letter to Shareholders
September 11, 2023
-
Nemaura Medical Completes 100 Patient Study for sugarBEAT® 24-hour Wear and Reports Interim Results
September 11, 2023
-
22nd Century Group Initiates Strategic Alternatives Process for Its Tobacco Assets
September 5, 2023
-
Biotricity Achieves $14 Million Revenue Run Rate in August 2023
August 30, 2023
-
Augmedix Achieves HITRUST Certification to Further Mitigate Risk in Third-Party Privacy, Security and Compliance
August 24, 2023
-
Nemaura Medical Announces SFDA Approval of sugarBEAT®
August 17, 2023
-
The Alkaline Water Company Reports Record Revenue of $63.8 Million in Fiscal Year 2023, Posts 16% Growth and Makes Significant Strides Toward Profitability
August 16, 2023
-
Biotricity Reports Strong Growth for its First Quarter Fiscal Year 2024 and Provides Financial Results and Business Updates
August 15, 2023
-
Nemaura Medical Reports Fiscal First Quarter 2024 Results and Provides Business Update
August 14, 2023
-
Biotricity to Host First Quarter Fiscal Year 2024 Financial Results and Business Update Call on August 15th
August 14, 2023